Persisting continuous visual perception disorder in a chronic MDMA ('ecstasy') user [2]

Australian and New Zealand Journal of Psychiatry

Volumn 36, Issue 2, 2002, Pages 266-267

  Passie, Torsten ^a   Schneider, Udo ^a   Emrich, Hinderk M ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

3,4 METHYLENEDIOXYAMPHETAMINE; CANNABIS; LYSERGIDE;

ADULT; ANXIETY NEUROSIS; CASE REPORT; CLINICAL FEATURE; COGNITIVE DEFECT; CONTROLLED STUDY; DRUG ABUSE; HUMAN; LETTER; MALE; PHYSICAL EXAMINATION; PSYCHOLOGIC ASSESSMENT; VISUAL CORTEX; VISUAL IMPAIRMENT; VISUAL SYSTEM EXAMINATION;

EID: 0036303515     PISSN: 00048674     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1614.2002.t01-1-01016.x     Document Type: Letter

References (3)

1. Cognitive performance in (+/-) 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') users: A controlled study
2. Altered serotonin innervation patterns in the forebrain of monkeys treated with (+/-) 3,4-methylenedioxymethamphetamine seven years previously: Factors influencing abnormal recovery
3. Neuroanatomic specifity and time course of alterations in rat brain serotoninergic pathways induced by MDMA (3,4-methylenedioxymethamphetamine)